Business Fact Book, Part 1


Book Description







EPA 440/1


Book Description




Druggists' Circular


Book Description







VYVANSE Drug Profile, 2023


Book Description

VYVANSE Drug Profile, 2023

This report focuses on VYVANSE and covers the following critical aspects of this drug:

  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources




Interim Reports


Book Description